Total Payments
$3,113
2024 Payments
$418.94
Companies
11
Transactions
135
Medicare Patients
128
Medicare Billing
$49,038
Payment Breakdown by Category
Food & Beverage$3,113 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,113 | 135 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $702.27 | 34 | $0 (2024) |
| Alkermes, Inc. | $686.68 | 32 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $531.18 | 24 | $0 (2024) |
| Neurocrine Biosciences, Inc. | $380.59 | 15 | $0 (2024) |
| BioXcel Therapeutics, Inc. | $268.42 | 7 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $238.92 | 10 | $0 (2023) |
| Lundbeck LLC | $87.19 | 4 | $0 (2024) |
| Vanda Pharmaceuticals Inc. | $80.91 | 3 | $0 (2020) |
| Indivior Inc. | $64.84 | 3 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $49.77 | 2 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $418.94 | 18 | Neurocrine Biosciences, Inc. ($82.33) |
| 2023 | $946.14 | 35 | Alkermes, Inc. ($245.38) |
| 2022 | $578.35 | 26 | Alkermes, Inc. ($177.81) |
| 2021 | $749.06 | 37 | Janssen Pharmaceuticals, Inc ($260.83) |
| 2020 | $396.08 | 18 | Janssen Pharmaceuticals, Inc ($122.48) |
| 2019 | $24.20 | 1 | Alkermes, Inc. ($24.20) |
All Payment Transactions
135 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $33.57 | General |
| 12/10/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug), ABILIFY ASIMTUFII | Food and Beverage | In-kind items and services | $21.26 | General |
| Category: PSYCHIATRY | ||||||
| 11/18/2024 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $16.20 | General |
| 10/09/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $24.96 | General |
| Category: CNS | ||||||
| 08/27/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $25.26 | General |
| Category: Neuroscience | ||||||
| 08/26/2024 | BioXcel Therapeutics, Inc. | IGALMI (Drug) | Food and Beverage | In-kind items and services | $24.56 | General |
| Category: NEUROSCIENCE | ||||||
| 07/09/2024 | Indivior Inc. | PERSERIS (Drug) | Food and Beverage | In-kind items and services | $19.08 | General |
| Category: BH | ||||||
| 07/02/2024 | Indivior Inc. | PERSERIS (Drug) | Food and Beverage | In-kind items and services | $19.08 | General |
| Category: BH | ||||||
| 06/05/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $19.20 | General |
| Category: CNS | ||||||
| 05/22/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $17.66 | General |
| Category: Neuroscience | ||||||
| 05/14/2024 | BioXcel Therapeutics, Inc. | IGALMI (Drug) | Food and Beverage | In-kind items and services | $21.83 | General |
| Category: NEUROSCIENCE | ||||||
| 03/13/2024 | Indivior Inc. | PERSERIS (Drug) | Food and Beverage | In-kind items and services | $26.68 | General |
| Category: BH | ||||||
| 03/13/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $17.69 | General |
| Category: CNS | ||||||
| 02/28/2024 | Lundbeck LLC | ABILIFY MAINTENA (Drug) | Food and Beverage | Cash or cash equivalent | $20.36 | General |
| Category: PSYCHIATRY | ||||||
| 02/14/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $28.85 | General |
| Category: Neuropsychiatry | ||||||
| 02/06/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $24.00 | General |
| Category: Neuropsychiatry | ||||||
| 01/23/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $29.22 | General |
| Category: Neuroscience | ||||||
| 01/10/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $29.48 | General |
| Category: Neuropsychiatry | ||||||
| 11/30/2023 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $21.90 | General |
| Category: Neuropsychiatry | ||||||
| 11/14/2023 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $29.22 | General |
| Category: Neuroscience | ||||||
| 10/31/2023 | Lundbeck LLC | ABILIFY MAINTENA (Drug) | Food and Beverage | Cash or cash equivalent | $24.35 | General |
| Category: PSYCHIATRY | ||||||
| 10/25/2023 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $30.18 | General |
| Category: Neuroscience | ||||||
| 10/19/2023 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $21.15 | General |
| Category: CNS | ||||||
| 10/11/2023 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $26.49 | General |
| Category: Neuropsychiatry | ||||||
| 09/27/2023 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $25.17 | General |
| Category: Neurology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 1 | 11 | 46 | $15,934 | $4,650 |
| 2022 | 1 | 23 | 152 | $45,493 | $14,126 |
| 2021 | 1 | 21 | 74 | $22,421 | $7,320 |
| 2020 | 4 | 73 | 234 | $72,113 | $22,943 |
Total Patients
128
Total Services
506
Medicare Billing
$49,038
Procedure Codes
7
All Medicare Procedures & Services
7 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 11 | 46 | $15,934 | $4,650 | 29.2% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 23 | 152 | $45,493 | $14,126 | 31.1% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 21 | 74 | $22,421 | $7,320 | 32.6% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 29 | 174 | $53,130 | $16,871 | 31.8% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 11 | 11 | $6,543 | $2,086 | 31.9% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2020 | 19 | 20 | $6,295 | $2,028 | 32.2% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 14 | 29 | $6,145 | $1,959 | 31.9% |
About Adeel Anwar
Adeel Anwar is a Psychiatry healthcare provider based in Brooklyn, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/08/2015. The National Provider Identifier (NPI) number assigned to this provider is 1255717609.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Adeel Anwar has received a total of $3,113 in payments from pharmaceutical and medical device companies, with $418.94 received in 2024. These payments were reported across 135 transactions from 11 companies. The most common payment nature is "Food and Beverage" ($3,113).
As a Medicare-enrolled provider, Anwar has provided services to 128 Medicare beneficiaries, totaling 506 services with total Medicare billing of $49,038. Data is available for 4 years (2020–2023), covering 7 distinct procedure/service records.
Ad
Practice Information
- Specialty Psychiatry
- Other Specialties Psychiatry
- Location Brooklyn, NY
- Active Since 08/08/2015
- Last Updated 09/19/2023
- Taxonomy Code 2084P0800X
- Entity Type Individual
- NPI Number 1255717609
Products in Payments
- INVEGA SUSTENNA (Drug) $702.27
- ABILIFY MAINTENA (Drug) $473.71
- ARISTADA (Drug) $458.38
- INGREZZA (Drug) $380.59
- IGALMI (Drug) $268.42
- AUSTEDO (Drug) $179.19
- Vivitrol (Drug) $135.16
- VIVITROL (Drug) $93.14
- HETLIOZ (Drug) $80.91
- REXULTI (Drug) $75.01
- PERSERIS (Drug) $64.84
- ABILIFY ASIMTUFII (Drug) $46.79
- UZEDY (Drug) $25.17
- ABILIFY MYCITE (Drug) $22.86
- Brainsway Deep TMS (Device) $22.00
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Brooklyn
Dr. Mark Owens, Do, DO
Psychiatry — Payments: $502,442
Psychiatry $502,442
Dr. Nancy Abdel-Wahab, M.d, M.D
Psychiatry — Payments: $194,999
Psychiatry $194,999
Louis Belzie, Md, Phd, MD, PHD
Psychiatry — Payments: $178,082
Psychiatry $178,082
Alexander Pinkusovich, Md, MD
Psychiatry — Payments: $111,246
Psychiatry $111,246
Dr. Mark Gurtovy, M.d, M.D
Psychiatry — Payments: $31,729
Psychiatry $31,729
Thresiamma Nidhiry, Md, MD
Psychiatry — Payments: $27,833
Psychiatry $27,833